Modernizing Opioid Treatment Access Act 2.0 of 2026
The source supplies the latest action, but no lifecycle stage.
Latest action (20 Jul 2026): Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
What this bill does
H.R. 9790, the Modernizing Opioid Treatment Access Act 2.0 of 2026, would allow certain licensed medical practitioners to prescribe methadone for opioid use disorder to be dispensed at pharmacies. This would be a change from current regulations that often require methadone to be dispensed at specialized opioid treatment programs. The bill specifies that prescribing would be done electronically, and dispensing would be in liquid or dispersible tablet forms. It also states that treatment provided through this method would be in addition to any other care an individual is receiving.
The bill affects licensed practitioners who meet specific criteria, such as addiction medicine physicians or psychiatrists with certain certifications, or others deemed qualified by the Secretary of Health and Human Services. It also affects individuals receiving treatment for opioid use disorder by potentially expanding their access to methadone medication. Pharmacies would be permitted to dispense methadone under these new provisions without requiring a separate registration. The bill includes provisions for informed consent regarding confidentiality differences and allows for telemedicine to be used for maintenance or detoxification treatment.
This bill was introduced in the House of Representatives on July 20, 2026, and has been referred to the Committees on Energy and Commerce and the Judiciary. As a newly introduced bill, it has not yet been acted upon by these committees. If it moves forward, it would need to pass both the House and the Senate and be signed by the President to become law. The bill specifies an effective date 180 days after enactment.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
20 Jul 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Common questions
- What does H.R. 9790 do?
- H.R. 9790, the Modernizing Opioid Treatment Access Act 2.0 of 2026, would allow certain licensed medical practitioners to prescribe methadone for opioid use disorder to be dispensed at pharmacies. This would be a change from current regulations that often require methadone to be dispensed at specialized opioid treatment programs. The bill specifies that prescribing would be done electronically, and dispensing would be in liquid or dispersible tablet forms. It also states that treatment provided through this method would be in addition to any other care an individual is receiving. The bill affects licensed practitioners who meet specific criteria, such as addiction medicine physicians or psychiatrists with certain certifications, or others deemed qualified by the Secretary of Health and Human Services. It also affects individuals receiving treatment for opioid use disorder by potentially expanding their access to methadone medication. Pharmacies would be permitted to dispense methadone under these new provisions without requiring a separate registration. The bill includes provisions for informed consent regarding confidentiality differences and allows for telemedicine to be used for maintenance or detoxification treatment. This bill was introduced in the House of Representatives on July 20, 2026, and has been referred to the Committees on Energy and Commerce and the Judiciary. As a newly introduced bill, it has not yet been acted upon by these committees. If it moves forward, it would need to pass both the House and the Senate and be signed by the President to become law. The bill specifies an effective date 180 days after enactment.
- Has H.R. 9790 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 9790. Check the latest action and official source below.
- Who sponsored H.R. 9790?
- H.R. 9790 was sponsored by Rep. Norcross, Donald [D-NJ-1] (D-NJ), with 5 cosponsors.
- What's the latest action on H.R. 9790?
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (20 Jul 2026).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
340B Rebate Model Delay Act
Lower Premiums, Faster Payments Act
More bills from Rep. Norcross, Donald [D-NJ-1]
Remedial Education Improvement Act
Peter McGuire Congressional Gold Medal Act
Battery Fire Prevention Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.